Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Exp Toxicol Pathol ; 62(3): 209-19, 2010 May.
Article de Anglais | MEDLINE | ID: mdl-19447591

RÉSUMÉ

Animals kept as pets may be considered sentinels for environmental factors to which humans could be exposed. Olfactory and respiratory epithelia are directly subjected to airborne factors, which could cause DNA lesions, and the alkaline comet assay is considered a reliable tool for the assessment of DNA damage. The objective of this work is to evaluate the extent of DNA damage by the comet assay of the olfactory and respiratory epithelia of dogs from different regions of the city of São Paulo, Brazil. Thirty-three clinically healthy dogs, aged 5 years or more, were used in the study, with 7 from the North region of São Paulo, 7 from the South region, 3 dogs from the East region, and 16 dogs from the West city region. Three dogs younger than 6 months were used as controls. DNA damage was analyzed by the alkaline comet assay. We observed no difference in histopathological analysis of olfactory and respiratory epithelia between dogs from different regions of São Paulo. Dogs older than 5 years presented significantly higher comet length in both olfactory and respiratory epithelia, when compared with controls, indicating DNA damage. When separated by regions, olfactory and respiratory epithelia presented similar DNA damage in dogs from different regions of São Paulo, corroborating with similar levels of particulate matter index (PM10) in all regions of the city. In this study, we report for the first time that the comet assay can be used to quantify the extent of DNA damage in dog olfactory and respiratory epithelia, and that comet length (DNA damage) increases with age, probably due to environmental factors. Air pollution, as measured by PM10, can be responsible for this DNA damage.


Sujet(s)
Pollution de l'air/effets indésirables , Altération de l'ADN , Muqueuse olfactive/anatomopathologie , Muqueuse respiratoire/anatomopathologie , Animaux , Brésil , Test des comètes , Chiens , Femelle , Mâle , Matière particulaire/effets indésirables
2.
J Comp Pathol ; 142(1): 84-8, 2010 Jan.
Article de Anglais | MEDLINE | ID: mdl-19643431

RÉSUMÉ

The development of prostate cancer is believed to be a multistep process, progressing sequentially from normal epithelium, to prostatic intraepithelial neoplasia (PIN) and, finally, to invasive neoplasia. Malignant stem cells within the basal cell layer of the prostatic epithelium are believed to play an important role in the failure of androgen-ablation therapy that occurs in the most advanced form of prostate cancer. The aim of the present study was to immunohistochemically characterize the lesions of canine PIN. Prostatic tissue from five dogs with PIN was compared with normal prostate tissue from nine further dogs. There was an increase in the number of basal epithelial cells in lesions consistent with PIN as defined by expression of the nuclear protein p63. These lesions had elevated expression of proliferating cell nuclear antigen (PCNA) and heterogeneous labelling for the nuclear androgen receptor (AR). These findings suggest that the basal cells present in PIN may play a role in canine prostate carcinogenesis and that the proliferation of these cells occurs despite the heterogeneous expression of the AR.


Sujet(s)
Protéines membranaires/biosynthèse , Antigène nucléaire de prolifération cellulaire/biosynthèse , Tumeur intraépithéliale prostate/métabolisme , Tumeurs de la prostate/métabolisme , Animaux , Marqueurs biologiques tumoraux/métabolisme , Chiens , Immunohistochimie , Mâle , Tumeur intraépithéliale prostate/anatomopathologie , Tumeurs de la prostate/anatomopathologie , Récepteurs aux androgènes/biosynthèse
3.
Vet Pathol ; 46(5): 846-59, 2009 Sep.
Article de Anglais | MEDLINE | ID: mdl-19429987

RÉSUMÉ

Previous studies showed that intercellular communication by gap junctions has a role in bone formation. The main connexin involved in the development, differentiation, and regulation of bone tissue is connexin (Cx) 43. In addition, Cx46 is also expressed, mostly localized within the trans-Golgi region. Alterations in the expression pattern and aberrant location of these connexins are associated with oncogenesis, demonstrating a deficient gap junctional intercellular communication (GJIC) capacity in neoplastic tissues. In this study, we evaluated normal and neoplastic bone tissues regarding the expression of Cx43 and Cx46 by immunofluorescence, gene expression of these connexins by real-time PCR, and their correlation with cell proliferation index and deposition of collagen. Fourteen neoplastic bone lesions, including 13 osteosarcomas and 1 multilobular tumor of bone, were studied. The mRNA levels of Cx43 were similar between normal and neoplastic bone tissue. In normal bone tissue, the Cx43 protein was found mainly in the intercellular membranes. However, in all bone tumors studied here, the Cx43 was present in both cell membranes and also aberrantly in the cytoplasm. Regarding only tumor samples, we determined a possible inverse correlation between Cx43 expression and cellular proliferation, although a positive correlation between Cx43 expression and collagen deposition was also noted. In contrast, Cx46 had lower levels of expression in neoplastic bone tissues when compared with normal bone and was found retained in the perinuclear region. Even though there are differences between these two connexins regarding expression in neoplastic versus normal tissues, we concluded that there are differences regarding the subcellular location of these connexins in normal and neoplastic dog bone tissues and suggest a possible correlation between these findings and some aspects of cellular proliferation and possibly differentiation.


Sujet(s)
Tumeurs osseuses/médecine vétérinaire , Connexine 43/métabolisme , Connexines/métabolisme , Maladies des chiens/métabolisme , Régulation de l'expression des gènes tumoraux/physiologie , Ostéosarcome/médecine vétérinaire , Animaux , Tumeurs osseuses/métabolisme , Prolifération cellulaire , Connexine 43/génétique , Connexines/génétique , ADN tumoral/composition chimique , ADN tumoral/génétique , Chiens , Femelle , Immunohistochimie , Kératines/métabolisme , Mâle , Microscopie de fluorescence/médecine vétérinaire , Ostéocalcine/métabolisme , Ostéonectine/métabolisme , Ostéosarcome/métabolisme , Antigène nucléaire de prolifération cellulaire/métabolisme , ARN messager/composition chimique , ARN messager/génétique , RT-PCR/médecine vétérinaire , Vimentine/métabolisme
4.
Vet Res Commun ; 33(6): 581-8, 2009 Aug.
Article de Anglais | MEDLINE | ID: mdl-19142741

RÉSUMÉ

Mast cell tumor (MCT) is one of the most prevalent neoplasms that affect the skin and soft tissue of dogs. Because mast cell tumors present a great variety of clinical appearance and behavior, their treatment becomes a challenge. While retinoids are well recognized as promising antitumor agents, there have been only a few reports about retinoids' effect on canine cancers. The aim of this study was to investigate the chemosensitivity of MCT grades II and III to all-trans retinoic acid (ATRA). Immediately after surgical resection, MCT were prepared for primary culture. Samples of MCTs were also fixed in formalin for histopathology and grading according to the classification of Patnaik et al. (Veterinary Pathology 21(5):469-474, 1984). The best results were obtained when neoplastic mast cells were co-cultivated with fibroblasts. Cultured mast cells were, then, treated with concentrations of 10(-4) to 10(-7) M of ATRA, in order to evaluate their chemosensitivity to this retinoid. MTT assay was performed to estimate cell growth and death. The highest level of mast cell chemosensivity was obtained at the dose of 10(-4) M (p < 0,002). MCT of grades II or III were equally susceptible to the treatment with ATRA. Cell death was observed on the first 24 h until 48 h. According to these results, ATRA may be a potential chemotherapeutic agent for the treatment of canine MCT.


Sujet(s)
Antinéoplasiques/pharmacologie , Maladies des chiens/traitement médicamenteux , Mastocytes/anatomopathologie , Mastocytose/médecine vétérinaire , Trétinoïne/pharmacologie , Animaux , Antinéoplasiques/administration et posologie , Lignée cellulaire tumorale , Prolifération cellulaire/effets des médicaments et des substances chimiques , Maladies des chiens/anatomopathologie , Chiens , Relation dose-effet des médicaments , Femelle , Mâle , Mastocytose/traitement médicamenteux , Mastocytose/anatomopathologie , Sels de tétrazolium/composition chimique , Thiazoles/composition chimique , Trétinoïne/administration et posologie , Cellules cancéreuses en culture
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE